Target intelligence / Profile preview

SR-related CTD-associated factor 4 (SCAF4)

Target
SCAF4
Molecular classification
Splicing factor, Transcription regulator, RNA-interacting protein, Other (anti-terminator, SR protein family)
01

Overview

SR-related CTD-associated factor 4 (SCAF4) is a member of the serine/arginine-rich (SR) splicing regulator family[3][4]. It encodes a protein of 1,147 amino acids, comprising a conserved CTD-interacting domain (CID) and an RNA recognition motif (RRM)[4]. SCAF4 interacts with the C-terminal domain (CTD) of the largest subunit of RNA polymerase II, functions as an anti-terminator by suppressing the premature usage of alternative polyadenylation sites, and links transcription with pre-mRNA splicing[1][2][3][4]. Together with SCAF8, it coordinates mRNA elongation and termination processes, ensuring that full-length, correctly processed mRNA is generated[4][7]. Loss of SCAF4 function causes broad deregulation of gene expression, alternative splicing, and truncated protein products, leading to neurodevelopmental disease phenotypes, intellectual disability, epilepsy, and association with ALS risk via regulatory variants[1][4][5][6]. Alternative splicing and transcript regulation mediated by SCAF4 have large effects on cell phenotype and function, but it does not fit in the classic mold of receptor, enzyme, or transporter drug targets.

Other names
SR-related CTD associated factor 4SCAF4KIAA1172SFRS15DKFZp434E098SRA4CTD-binding SR-like protein RA4Splicing factor, arginine/serine-rich 15FZSSR-like CTD-associated factor 4pre-mRNA splicing SR protein RA4Splicing factor serine alanine 15
02

Biological functions

mRNA processingmRNA splicing regulationmRNA transcription termination controlPolyadenylation site selectionPrevention of premature mRNA transcript termination (anti-terminator function)Coordination of transcriptional elongation and terminationEnsures proper link between transcription and splicing
03

Disease associations

Neurodevelopmental disorder (variants in SCAF4 cause mild to moderate intellectual disability, epilepsy, behavioral abnormalities, and skeletal anomalies)Rare syndromic intellectual disability (as in Fliedner-Zweier syndrome)Amyotrophic lateral sclerosis (ALS) (variants and transcript regulation in the SCAF4 gene may modify ALS risk; specific variants in the 3′UTR are associated with disease risk)
04

Safety considerations

No targeted therapeutics or interventions reported.Loss-of-function mutations in SCAF4 are linked to broad transcriptional dysregulation and disease, emphasizing the essential nature of SCAF4 for normal cellular functionTherapeutic modulation would risk widespread mRNA processing defects.
05

Biomarkers

Genetic variants and structural sequence variations (SSVs), especially in the 3′UTR region, can serve as disease-modifying biomarkers relevant to ALS or neurodevelopmental disordersLoss-of-function alleles act as molecular markers for specific neurodevelopmental phenotypes

Beyond the preview

Go deeper on SR-related CTD-associated factor 4 (SCAF4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SR-related CTD-associated factor 4 (SCAF4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call